Cetrotide, a GnRH antagonist used in IVF, is often more expensive than alternatives like Leuprorelin but offers a shorter treatment duration, potentially reducing overall costs.

Comparing Cetrotide with other IVF drugs, it’s pricier upfront but may decrease the cycle length and associated costs, making it a valuable option for specific treatment plans.

While Cetrotide is effective in IVF for preventing premature ovulation, its cost is higher compared to some GnRH agonists, but its protocol duration is shorter, impacting total expense.

Cetrotide costs more per dose than some competitors but can lead to fewer clinic visits and lower ancillary expenses, making it a cost-effective option depending on the IVF protocol used.